Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Manzo Pharmaceuticals, Inc.Manzo Pharmaceuticals, Inc.-19.7-28%--0.7
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.00 Million
Enterprise Value$9.73 Million
Earnings per Share$0
Beta-0.54
Outstanding Shares5,000,000,000

Return

Return on Equity27.87%ROE
Return on Assets-80.84%
Return on Invested Capital24.91%

Valuation & Multiples

P/E Ratio-19.67P/E Ratio
PEG19.55PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue162.24
Enterprise Value to EBIT-3.33
Enterprise Value to Net Income-3
Total Debt to Enterprise0.9
Debt to Equity-0.74Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Manzo Pharmaceuticals, Inc.

12 employees
CEO: Kenneth Manzo

Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a paten...